Bone Graft Substitutes Market

1. Bone Graft Substitutes Market Share, Key Strategies, Size, Growth, Application, Segmentation, Trends and Opportunities Forecast to 2030 Bone Graft Substitutes Market Synopsis: Market Research Future (MRFR)’s latest study reveals that the Bone Graft Substitute Market size to reach USD 2.3 billion by 2030 at 7.1% CAGR during the forecast period 2022-2030. The increasing prevalence of diseases related to bones has intensified the demand for bone graft substitutes. Additionally, the rising awareness about the developments in bone graft substitutes coupled with rising healthcare expenditure is likely to augment the market size and revenue over the next couple of years. The painful procedure related to autografts have paved the way for developments in the bone graft substitutes market. Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise. It is projected to aid the proliferation of the market in the forthcoming years by accelerating its adoption. The growth of the bone graft substitutes market is guided by the factors such as increasing orthopedic problems, exponential geriatric population, and rising demand for reconstructive orthopedic treatments. The adoption of bone graft substitutes in the oral healthcare sector is another factor responsible for catalysing the growth of the bone graft substitutes market through the assessment period. The bone graft substitutes market is poised to remain highly lucrative in the foreseeable future. However, risks associated with disease transmission in allografts and xenograft as well as graft rejection, improper fixation, etc. are prognosticated to restrict the market expansion over the forecast period. The COVID-19 pandemic has had a significant impact on the bone graft substitutes market. The pandemic has led to a decrease in elective surgeries due to restrictions on non-essential medical procedures . However, as vaccination rates increase and restrictions are lifted, the market is expected to recover in the coming years. In conclusion, the global bone graft substitutes market is expected to grow significantly over the next few years due to increasing prevalence of orthopedic diseases and disorders and rising geriatric population. Bone graft substitutes offer several advantages over traditional bone grafts and are expected to gain wider acceptance in the coming years. Market Segmentation: By type, the global bone graft substitutes market outlook is segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others. By application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others. Competitive Dashboard:

2. Regional Insights: By region, the global bone graft substitutes market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas accounted for the largest share of the global market in 2016. It is expected to retain a significant share of the market by the end of 2027 striking a CAGR of 6.1%. The growth is attributable to the technological advancements in health care, the presence of key players, etc. The developed healthcare The global bone graft substitutes market players include ACE Surgical Supply Company, Inc., Dentium Co., Ltd., BioHorizons IPH, Inc., Dentsply Sirona, Medtronic plc, Stryker Corporation, Zimmer Biomet, and Institut Straumann AG. sector of the U.S. is poised to be one of the primary revenue generators in the regional bone graft substitutes market. Europe is the second largest market for bone graft substitutes. It is estimated to thrive at 6.76% CAGR owing to increasing awareness about bone graft substitutes and rising healthcare expenditure. Meanwhile, Asia Pacific is set to register a relatively higher CAGR of 6.85% during the forecast period. The presence of fast-developing economies such as China and India are immensely supporting the growth of the bone graft substitutes market in the region. The trend is likely to perpetuate over the next couple of years. The Middle East & Africa is expected to exhibit steady growth due to the developments in the healthcare sector in Gulf nations. However, the poor socio-economic situation in African regions remains an impediment to the market growth. Industry Developments: In August 2018, BoneSupport, a Scandinavian orthobiologics company, won Health Canada approval for Cerament G bone graft substitute. In September 2018, Baxter International Inc., an American healthcare company, received FDA clearance for its Actifuse Flow bone graft substitute. It shall be used in orthopedic surgical procedures. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013

3. United States of America +1 628 258 0071 Email: sales@marketresearchfuture.com